I agree that this site is using cookies. You can find further informations here.
X
Bergeron, Raymond J.
258  results:
Search for persons X
?
1

Niche for polyamine inhibition in treatment of metastatic p..:

Ghayee, Hans K. ; Hatch, Heather ; Bergeron, Raymond J....
European Journal of Clinical Investigation.  54 (2024)  5 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
2

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polya..:

Tevosian, Sergei G ; Pacak, Karel ; Bergeron, Raymond...
Journal of the Endocrine Society.  4 (2020)  Supplement_1 - p. , 2020
Link: https://doi.org/10.1210/..
 
?
3

SBP-101 Produces Atrophy of the Exocrine Pancreas and Exocr..:

Walker, Michael ; Gagnon, Suzanne ; Kiorpes, Andy...
Gastroenterology.  152 (2017)  5 - p. S901 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Metabolically programmed iron chelators:

Bergeron, Raymond J. ; Bharti, Neelam ; McManis, James S..
Bioorganic & Medicinal Chemistry.  23 (2015)  17 - p. 5954-5971 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Desferrithiocin: A Search for Clinically Effective Iron Che..:

Bergeron, Raymond J. ; Wiegand, Jan ; McManis, James S..
Journal of Medicinal Chemistry.  57 (2014)  22 - p. 9259-9291 , 2014
Link: https://doi.org/10.1021/..
 
?
6

Substituent Effects on Desferrithiocin and Desferrithiocin ..:

Bergeron, Raymond J. ; Wiegand, Jan ; Bharti, Neelam.
Journal of Medicinal Chemistry.  55 (2012)  16 - p. 7090-7103 , 2012
Link: https://doi.org/10.1021/..
 
?
7

Synthesis of heterobactins A and B and Nocardia heterobacti:

Bergeron, Raymond J. ; Singh, Shailendra ; Bharti, Neelam
Tetrahedron.  67 (2011)  18 - p. 3163-3169 , 2011
Link: https://doi.org/10.1016/..
 
?
8

Desferrithiocin analogue iron chelators: iron clearing effi..:

Bergeron, Raymond J. ; Wiegand, Jan ; Bharti, Neelam..
BioMetals.  24 (2010)  2 - p. 239-258 , 2010
Link: https://doi.org/10.1007/..
 
?
9

The Impact of Polyether Chain Length on the Iron Clearing E..:

Bergeron, Raymond J. ; Bharti, Neelam ; Wiegand, Jan...
Journal of Medicinal Chemistry.  53 (2010)  7 - p. 2843-2853 , 2010
Link: https://doi.org/10.1021/..
 
?
10

Vibriobactin Antibodies: A Vaccine Strategy:

Bergeron, Raymond J. ; Bharti, Neelam ; Singh, Shailendra...
Journal of Medicinal Chemistry.  52 (2009)  12 - p. 3801-3813 , 2009
Link: https://doi.org/10.1021/..
 
?
11

Design, Synthesis, and Testing of Non-Nephrotoxic Desazades..:

Bergeron, Raymond J. ; Wiegand, Jan ; McManis, James S...
Journal of Medicinal Chemistry.  51 (2008)  13 - p. 3913-3923 , 2008
Link: https://doi.org/10.1021/..
 
?
12

Desferrithiocin Analogues and Nephrotoxicity:

Bergeron, Raymond J. ; Wiegand, Jan ; McManis, James S...
Journal of Medicinal Chemistry.  51 (2008)  19 - p. 5993-6004 , 2008
Link: https://doi.org/10.1021/..
 
?
13

Impact of the 3,6,9-Trioxadecyloxy Group on Desazadesferrit..:

Bergeron, Raymond J. ; Wiegand, Jan ; Bharti, Neelam..
Journal of Medicinal Chemistry.  50 (2007)  14 - p. 3302-3313 , 2007
Link: https://doi.org/10.1021/..
 
?
14

The Design, Synthesis, and Evaluation of Organ-Specific Iro..:

Bergeron, Raymond J. ; Wiegand, Jan ; McManis, James S..
Journal of Medicinal Chemistry.  49 (2006)  24 - p. 7032-7043 , 2006
Link: https://doi.org/10.1021/..
 
?
15

(S)-4,5-Dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-th..:

Bergeron, Raymond J. ; Wiegand, Jan ; McManis, James S....
Journal of Medicinal Chemistry.  49 (2006)  9 - p. 2772-2783 , 2006
Link: https://doi.org/10.1021/..
 
1-15